CLOROX CO /DE/
Business
The Clorox Company is a multinational manufacturer and marketer of consumer and professional cleaning, disinfecting, food, water-filtration, and personal care products. Its portfolio includes leading brands such as Clorox bleach, Pine-Sol, Glad bags, Fresh Step cat litter, Hidden Valley dressings, Brita water filters, and Burt's Bees personal care products. The Company operates through four reportable segments, selling primarily through mass retailers, grocery stores, warehouse clubs, e-commerce channels, and distributors across approximately 100 markets.
Summary from 10-K filed 2025-08-08
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net sales | 7,104 | 7,093 | 7,389 | 7,107 | 7,341 | |
| Cost of products sold | 3,891 | 4,045 | 4,481 | 4,562 | 4,142 | |
| Gross profit | 3,213 | 3,048 | 2,908 | 2,545 | 3,199 | |
| Selling and administrative expenses | 1,124 | 1,167 | 1,183 | 954 | 1,004 | |
| Advertising costs | 770 | 832 | 734 | 709 | 790 | |
| Research and development costs | 121 | 126 | 138 | 132 | 149 | |
| Loss on divestiture | 118 | 240 | 0 | 0 | — | |
| Pension settlement charge | 0 | 171 | 0 | 0 | — | |
| Goodwill, trademark and other asset impairments | 0 | 0 | 445 | 0 | 329 | |
| Interest expense | 88 | 90 | 90 | 106 | 99 | |
| Other (income) expense, net | −86 | 24 | 80 | 37 | −72 | |
| Earnings before income taxes | 1,078 | 398 | 238 | 607 | 900 | |
| Income taxes | 254 | 106 | 77 | 136 | 181 | |
| Net earnings | 824 | 292 | 161 | 471 | 719 | |
| Less: Net earnings attributable to noncontrolling interests | 14 | 12 | 12 | 9 | 9 | |
| Net earnings attributable to Clorox | 810 | 280 | 149 | 462 | 710 | |
| Basic net earnings per share (in dollars per share) | 6.56 | 2.26 | 1.21 | 3.75 | 5.66 | |
| Diluted net earnings per share (in dollars per share) | 6.52 | 2.25 | 1.2 | 3.73 | 5.58 | |
| Basic (in shares) | 124 | 124 | 124 | 123 | 126 | |
| Diluted (in shares) | 124 | 125 | 124 | 124 | 127 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 167 | 202 | 367 | 183 | 319 | |
| Receivables, net | 821 | 695 | 688 | 681 | 604 | |
| Inventories, net | 523 | 637 | 696 | 755 | 752 | |
| Prepaid expenses and other current assets | 97 | 88 | 77 | 106 | 154 | |
| Total current assets | 1,608 | 1,622 | 1,828 | 1,725 | 1,829 | |
| Property, plant and equipment, net | 1,267 | 1,315 | 1,345 | 1,334 | 1,302 | |
| Operating lease right-of-use assets | 333 | 360 | 346 | 342 | 332 | |
| Goodwill | 1,229 | 1,228 | 1,252 | 1,558 | 1,575 | |
| Trademarks, net | 502 | 538 | 543 | 687 | 693 | |
| Other intangible assets, net | 64 | 143 | 169 | 197 | 225 | |
| Other assets | 558 | 545 | 462 | 315 | 378 | |
| Total assets | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 | |
| Notes and loans payable | 4 | 4 | 50 | 237 | 0 | |
| Current operating lease liabilities | 87 | 84 | 87 | 78 | 81 | |
| Accounts payable and accrued liabilities | 1,828 | 1,486 | 1,659 | 1,469 | 1,675 | |
| Total current liabilities | 1,919 | 1,574 | 1,917 | 1,784 | 2,056 | |
| Long-term debt | 2,484 | 2,481 | 2,477 | 2,474 | 2,484 | |
| Long-term operating lease liabilities | 305 | 334 | 310 | 314 | 301 | |
| Other liabilities | 351 | 848 | 825 | 791 | 834 | |
| Deferred income taxes | 20 | 22 | 28 | 66 | 67 | |
| Total liabilities | 5,079 | 5,259 | 5,557 | 5,429 | 5,742 | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of June 30, 2025 and 2024; and 122,694,263 and 124,201,807 shares outstanding as of June 30, 2025 and 2024, respectively | 131 | 131 | 131 | 131 | 131 | |
| Additional paid-in capital | 1,319 | 1,288 | 1,245 | 1,202 | 1,186 | |
| Retained earnings | 432 | 250 | 583 | 1,048 | 1,036 | |
| Treasury stock, at cost: 8,047,198 and 6,539,654 shares as of June 30, 2025 and 2024, respectively | −1,404 | −1,186 | −1,246 | −1,346 | −1,396 | |
| Accumulated other comprehensive net (loss) income | −157 | −155 | −493 | −479 | −546 | |
| Total Clorox stockholders equity | 321 | 328 | 220 | 556 | 411 | |
| Noncontrolling interests | 161 | 164 | 168 | 173 | 181 | |
| Total stockholders equity | 482 | 492 | 388 | 729 | 592 | |
| Total liabilities and stockholders equity | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 219 | 235 | 236 | 224 | 211 | |
| Stock-based compensation | 81 | 74 | 73 | 52 | 50 | |
| Deferred income taxes | −18 | −100 | −149 | 5 | −32 | |
| Loss on divestiture | 112 | 238 | 0 | 0 | — | |
| Other | −26 | 26 | 38 | 19 | 10 | |
| Receivables, net | −145 | −34 | −13 | −84 | 82 | |
| Inventories, net | 63 | 55 | 58 | −18 | −282 | |
| Prepaid expenses and other current assets | −9 | 25 | −1 | 16 | −30 | |
| Accounts payable and accrued liabilities | −124 | −140 | 157 | −47 | 311 | |
| Operating lease right-of-use assets and liabilities, net | 2 | 0 | 1 | −1 | −2 | |
| Income taxes payable/prepaid | 2 | −147 | 152 | 35 | −90 | |
| Net cash provided by operations | 981 | 695 | 1,158 | 786 | 1,276 | |
| Capital expenditures | −220 | −212 | −228 | −251 | −331 | |
| Proceeds from divestiture, net of cash divested | 128 | 17 | 0 | 0 | — | |
| Other | −2 | 20 | 5 | 22 | −36 | |
| Net cash used for investing activities | −94 | −175 | −223 | −229 | −452 | |
| Notes and loans payable, net | 0 | −45 | −188 | 237 | 0 | |
| Treasury stock purchased | −332 | 0 | 0 | −25 | −905 | |
| Cash dividends paid to Clorox stockholders | −602 | −595 | −583 | −571 | −558 | |
| Cash dividends paid to noncontrolling interests | −16 | −16 | −15 | −15 | −31 | |
| Issuance of common stock for employee stock plans and other | 26 | 1 | 33 | 5 | 103 | |
| Net cash used for financing activities | −924 | −655 | −753 | −689 | −1,391 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | −26 | 0 | −6 | 12 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | −37 | −161 | 182 | −138 | −555 | |
| Interest paid | 97 | 102 | 99 | 89 | 89 | |
| Income taxes paid, net of refunds | 264 | 347 | 73 | 100 | 303 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is CLOROX CO /DE/'s CIK number?
CLOROX CO /DE/'s SEC CIK number is 0000021076 (21076). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find CLOROX CO /DE/'s SEC filings?
All of CLOROX CO /DE/'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did CLOROX CO /DE/ last report earnings?
CLOROX CO /DE/ (CLX) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000021076-26-000016). This is CLOROX CO /DE/'s most recent earnings filing of record — not a forecast of its next earnings date.
What is CLOROX CO /DE/'s most recent earnings 8-K?
CLOROX CO /DE/'s latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0000021076-26-000016. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View CLOROX CO /DE/'s latest earnings 8-K →
Look up any company's CIK number →